FDA tells Johnson & Johnson to toss 60 million Covid vaccine doses

The doses were produced at a plant in Baltimore that was previously found to have contamination issues.

6/11/2021 10:05:00 PM

The FDA has told Johnson & Johnson to discard about 60,000,000 doses of its Covid-19 vaccine that were produced at a troubled plant in Baltimore, according to 2 people familiar with the matter.

The doses were produced at a plant in Baltimore that was previously found to have contamination issues.

Michael Robinson Chavez / The Washington Post via Getty Images fileJune 11, 2021, 6:36 PM UTCByandHeidi PrzybylaThe Food and Drug Administration has told Johnson & Johnson to discard about 60 million doses of its Covid-19 vaccine that were produced at a troubled plant in Baltimore, according to two people familiar with the matter.

What's Up: August 2021 Skywatching Tips from NASA U.S. Economy Surpasses Pre-Pandemic Size Rep. Dean: McCarthy lifts up the most vulgar members of his party

The FDA ordered the vaccines to be tossed after determining they were “not suitable for use,” the agency said Friday. But the FDA plans to allow Johnson & Johnson to distribute 10 million doses that were manufactured at the same facility, according to the two people familiar with the decision.

The agency said in a press release that it authorized some batches for use but not others, but it didn’t provide specific numbers.April 21, 202101:03“These actions followed an extensive review of records, including the production history of the facility and the testing performed to evaluate the quality of the product,” Dr. Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research, said in the release. headtopics.com

The FDA’s decision to tell Johnson & Johnson to dump the vaccines was first reported by theNew York Times.“Since establishing our COVID-19 vaccine program, Johnson & Johnson has committed to producing safe, high-quality vaccines in order to bring health and hope to people everywhere,” Kathy Wengel, Johnson & Johnson's chief global supply chain officer, said in a statement.

“Today’s decisions represent progress in our continued efforts to make a difference in this pandemic on a global scale, and we appreciate the close collaboration with the FDA and global health authorities.”The doses in question were produced at the Emergent BioSolutions plant in Baltimore. The facility threw away ingredients for 15 million doses in late April because of contamination with materials from the AstraZeneca vaccine, which was also manufactured at the plant.

The FDA’s subsequent inspection of the Baltimore facilityit had serious problems with unsanitary conditions and had failed to properly train workers.Following the inspection, the agency required Johnson & Johnson to take full control of the facility.

Public health experts in countries where there are no vaccines have told NBC News they prefer the one-shot Johnson & Johnson vaccine citing its ease of administration since second appointments are not necessary.June 10, 202101:57In approving the 10 million doses for distribution in the United States or abroad, the FDA updated its letter of authorization for J&J to help “facilitate potential export to other countries.” The FDA is still reviewing other batches from the Baltimore plant for potential distribution, according to the agency’s press release. headtopics.com

It’s officially subpoena time on Capitol Hill Opinion | Lives are about to be ruined — and a Democratic Congress is on vacation An historian had lunch with the MyPillow Guy, and we are basically doomed

Friday’s action followed a move earlier in the week by the FDA to extend the shelf life of Johnson & Johnson doses from three months to four and a half months.that hundreds of thousands and potentially millions of J&J doses are sitting on shelves around the country and were set to expire soon.

Laura StricklerLaura Strickler is an investigative producer in the NBC News Investigative Unit based in Washington. Read more: NBC News »

Jeff Bezos' spaceflight: Live updates

Jeff Bezos will fly to space today on the first crewed flight of the New Shepard, the rocket ship made by his space company, Blue Origin. Follow here for live updates.

matteroffacttv 60 million people waiting longer for vax.

Johnson & Johnson says FDA has extended shelf life of single-dose COVID vaccine by six weeksOriginal three-month expiration dates loomed at end of June. It’s better to get sick and trust drugs that have been around for years. These Vaccines are experimental. These vaccines are more dangerous than getting covid and getting Hydroxychoroquine also it is more effective against Covid-19 than the vaccines.

Johnson & Johnson Doses At Risk Of Expiring As FDA Mulls ExtensionThe FDA's decision to pause distribution of the one-dose vaccine is credited with damaging its reputation among Americans. ...well duh can we say well duh? Oh what a surprise! (Sarcasm) Well we should all get these vaccination shots because if not we’re going to be social Piranhas and be cast from society

FDA extends expiration dates on Johnson & Johnson vaccine dosesJohnson & Johnson says US regulators have extended the expiration date on millions of doses of its Covid-19 vaccine by an extra 6 weeks. I will be asking to see the date on the vial this weekend JoshMelko

Johnson & Johnson says FDA has approved extended vaccine expiration dateJohnson & Johnson announced Thursday that the Food and Drug Administration (FDA) has authorized an extension of its COVID vaccine's shelf life from three months to 4.5 months.Why it matters: Amid a slowdown in vaccine uptake, a number of state health officials had been sounding the alarm that hundreds of thousands of single-shot J&J doses could expire this month.Get market news worthy of your time with Axios Markets. Subscribe for free.Prior to the FDA's extension, which the agency confirmed to

Moderna files for FDA authorization of Covid vaccine for 12 to 17-year-oldsModerna has filed for FDA emergency use authorization of its Covid-19 vaccine for kids ages 12 to 17, which could expand the number of shots available to middle and high school students across the country. NBC News’ Dr. John Torres has the latest. Is it an emergency for this age group range to be trying a vaccine that has no longitudinal study? nice A lot of pressure

Moderna asks FDA to clear Covid vaccine for adolescents 12 to 17If approved, it would likely dramatically expand the number of Covid vaccine shots available to middle and high school students ahead of the next school year.